107 related articles for article (PubMed ID: 11118250)
1. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5.
Jenkinson C; Fitzpatrick R
J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):70-3. PubMed ID: 11118250
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey.
Jenkinson C; Fitzpatrick R; Swash M; Jones G
Clin Rehabil; 2007 Mar; 21(3):266-72. PubMed ID: 17329284
[TBL] [Abstract][Full Text] [Related]
3. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).
Jenkinson C; Norquist JM; Fitzpatrick R
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):242-5. PubMed ID: 12531959
[TBL] [Abstract][Full Text] [Related]
4. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
5. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
[TBL] [Abstract][Full Text] [Related]
6. The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): evidence for a method of imputing missing data.
Jenkinson C; Harris R; Fitzpatrick R
Amyotroph Lateral Scler; 2007 Apr; 8(2):90-5. PubMed ID: 17453636
[TBL] [Abstract][Full Text] [Related]
7. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
8. The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients.
Jenkinson C; Levvy G; Fitzpatrick R; Garratt A
J Neurol Sci; 2000 Nov; 180(1-2):94-100. PubMed ID: 11090872
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.
Jenkinson C; Fitzpatrick R; Brennan C; Bromberg M; Swash M
J Neurol; 1999 Nov; 246 Suppl 3():III16-21. PubMed ID: 10631656
[TBL] [Abstract][Full Text] [Related]
10. Validity and Reliability of the Turkish Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire.
Alankaya N; Tülek Z; Özakgül A; Kaya A; Dik A
J Neurosci Nurs; 2019 Oct; 51(5):253-258. PubMed ID: 31469706
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.
Shamshiri H; Eshraghian MR; Ameli N; Nafissi S
Iran J Neurol; 2013; 12(3):102-5. PubMed ID: 24250914
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration.
Norquist JM; Fitzpatrick R; Jenkinson C
Qual Life Res; 2004 Oct; 13(8):1409-14. PubMed ID: 15503836
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40.
Jenkinson C; Fitzpatrick R; Brennan C; Swash M
Amyotroph Lateral Scler Other Motor Neuron Disord; 1999 Dec; 1(1):33-40. PubMed ID: 12365067
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and motor impairment in ALS: Italian validation of ALSAQ.
Palmieri A; Sorarù G; Lombardi L; D'Ascenzo C; Baggio L; Ermani M; Pegoraro E; Angelini C
Neurol Res; 2010 Feb; 32(1):32-40. PubMed ID: 20092693
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) scale in the Portuguese language.
Pavan K; Marangoni BE; Zinezzi MO; Schmidt KB; Oliveira BC; Buainain RP; Lianza S
Arq Neuropsiquiatr; 2010 Feb; 68(1):48-51. PubMed ID: 20339652
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis.
Gołąb-Janowska M; Honczarenko K; Stankiewicz J
Neurol Neurochir Pol; 2010; 44(6):560-6. PubMed ID: 21225518
[TBL] [Abstract][Full Text] [Related]
17. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40).
Jenkinson C; Peto V; Jones G; Fitzpatrick R
Clin Rehabil; 2003 Jul; 17(4):380-5. PubMed ID: 12785246
[TBL] [Abstract][Full Text] [Related]
18. Trends of quality of life changes in amyotrophic lateral sclerosis patients.
Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S
J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598
[TBL] [Abstract][Full Text] [Related]
19. Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure.
Abdulla S; Vielhaber S; Körner S; Machts J; Heinze HJ; Dengler R; Petri S
J Neurol; 2013 Sep; 260(9):2242-55. PubMed ID: 23736973
[TBL] [Abstract][Full Text] [Related]
20. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19.
Brooks BR; Pioro EP; Katz J; Takahashi F; Takei K; Zhang J; Apple S
Muscle Nerve; 2022 Feb; 65(2):180-186. PubMed ID: 34816454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
